|
Volumn 21, Issue 2, 2008, Pages 430-
|
Letter to the editor
|
Author keywords
[No Author keywords available]
|
Indexed keywords
HYALURONIC ACID;
METHACHOLINE;
PHOSPHATE BUFFERED SALINE;
PLACEBO;
SALBUTAMOL;
DIAGNOSTIC AGENT;
IMMUNOLOGICAL ADJUVANT;
METHACHOLINE CHLORIDE;
ADULT;
ASTHMA;
BRONCHOSPASM;
DISEASE DURATION;
DRUG EFFECT;
EXERCISE;
FORCED EXPIRATORY VOLUME;
HEADACHE;
HUMAN;
INFECTION;
LETTER;
MOLECULAR WEIGHT;
PRIORITY JOURNAL;
SPUTUM ANALYSIS;
CLINICAL TRIAL;
CONTROLLED CLINICAL TRIAL;
CONTROLLED STUDY;
CROSSOVER PROCEDURE;
EXERCISE INDUCED ASTHMA;
INHALATION TEST;
INHALATIONAL DRUG ADMINISTRATION;
NOTE;
PATHOPHYSIOLOGY;
RANDOMIZED CONTROLLED TRIAL;
ADJUVANTS, IMMUNOLOGIC;
ADMINISTRATION, INHALATION;
ADULT;
ASTHMA, EXERCISE-INDUCED;
BRONCHIAL PROVOCATION TESTS;
BRONCHOCONSTRICTION;
CROSS-OVER STUDIES;
FORCED EXPIRATORY VOLUME;
HUMANS;
HYALURONIC ACID;
METHACHOLINE CHLORIDE;
|
EID: 40149088320
PISSN: 10945539
EISSN: 15229629
Source Type: Journal
DOI: 10.1016/j.pupt.2007.04.001 Document Type: Letter |
Times cited : (6)
|
References (6)
|